SpringWorks Therapeutics
(NASDAQ) SWTX
SpringWorks Therapeutics Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$219.67M
Net Income (TTM)
$253.93M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
SWTX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout SpringWorks Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
368
CEO
Saqib Islam
Website
www.springworkstx.comHeadquarters
Stamford, CT 06902, US
SWTX Financials
Key Financial Metrics (TTM)
Gross Margin
92%
Operating Margin
-1%
Net Income Margin
-1%
Return on Equity
-36%
Return on Capital
-38%
Return on Assets
-32%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$179.04M
Operating Income
$278.13M
EBITDA
$274.66M
Operating Cash Flow
$175.60M
Capital Expenditure
$4.45M
Free Cash Flow
$180.05M
Cash & ST Invst.
$307.99M
Total Debt
$7.91M
SpringWorks Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$49.09M
+133.7%
Gross Profit
$45.56M
+138.8%
Gross Margin
92.81%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
368
N/A
Net Income
$83.19M
+4.8%
EBITDA
$82.09M
+11.9%
Quarterly Fundamentals
Net Cash
$280.48M
-34.8%
Accounts Receivable
$40.35M
+159.8%
Inventory
$12.42M
+138.1%
Long Term Debt
$5.69M
+2.0%
Short Term Debt
$1.70M
-13.4%
Return on Assets
-31.76%
N/A
Return on Invested Capital
-38.26%
N/A
Free Cash Flow
$68.79M
+13.5%
Operating Cash Flow
$68.76M
+12.9%